MPZ rs281865122: What Your Genotype Means
The rs281865122 variant is a rare genetic change located within the MPZ gene. It is classified as pathogenic and is associated with Charcot-Marie-Tooth disease type 1b, a condition that affects the peripheral nervous system.
What each genotype means
Typical MPZ gene profile
This genotype represents the common, non-pathogenic sequence at this position in the MPZ gene. It is considered the reference sequence in clinical databases and is not associated with the development of Charcot-Marie-Tooth disease type 1b.
This is the most common genotype found in the general population.
Increased risk of neuropathy
This genotype is classified as pathogenic and is associated with Charcot-Marie-Tooth disease type 1b, a condition that affects the myelin sheath of peripheral nerves. Individuals with this variant may experience muscle weakness and sensory loss, though the age of onset and severity can vary significantly between individuals.
This is a rare genotype that is not commonly found in the general population.
Increased risk of neuropathy
This genotype is classified as pathogenic and is linked to the development of Charcot-Marie-Tooth disease type 1b. Carrying this variant may lead to progressive nerve damage, resulting in muscle weakness and sensory problems in the hands and feet.
This is a very rare genotype that is not commonly found in the general population.
Understanding the Variant and Its Location
The variant rs281865122 is a specific change in the human genome located on chromosome 1. In genetic databases, it is identified by its rsID, which serves as a unique label for researchers to track this specific position. This variant occurs within the MPZ gene, which provides instructions for creating a protein essential for the structure and function of the myelin sheath. The myelin sheath is the protective coating that surrounds nerve fibers, allowing for the efficient transmission of electrical signals throughout the body. When a variant occurs in this gene, it can potentially disrupt the production or function of this critical protein, leading to changes in how nerves communicate with muscles and sensory organs.
The Role of the MPZ Gene
The MPZ gene encodes Myelin Protein Zero, a major structural component of the myelin sheath in the peripheral nervous system. This protein acts like a glue, helping to hold the layers of the myelin sheath together, which is vital for the insulation of nerve axons. Proper myelination is necessary for the rapid conduction of nerve impulses. Mutations or variants in the MPZ gene are well-documented in scientific literature for their role in various inherited neuropathies. Because the protein is so central to nerve integrity, even small changes in its genetic code can have significant downstream effects on nerve health, often manifesting as demyelinating or axonal neuropathies that impact motor and sensory functions.
Research and Clinical Associations
Scientific research, including data from ClinVar, has classified rs281865122 as a pathogenic variant. It is specifically linked to Charcot-Marie-Tooth disease type 1b (CMT1B). CMT1B is a hereditary condition characterized by the progressive degeneration of peripheral nerves, which can lead to muscle weakness, atrophy, and sensory loss, particularly in the feet and legs. The evidence for this association is considered moderate to strong in clinical genetics, as it is identified in patients presenting with the clinical features of this neuropathy. It is important to note that the clinical expression of MPZ-related conditions can be highly variable, ranging from severe, early-onset forms to milder, late-onset presentations. Researchers continue to study how this specific variant alters protein function to better understand the underlying mechanisms of the disease.
Population Frequency
The rs281865122 variant is considered rare across global populations. Because it is not a common polymorphism, it is not typically found in the general population at high frequencies. Most individuals do not carry this specific variant. Its rarity means that it is primarily identified in clinical settings when individuals are being tested for hereditary neuropathies after experiencing symptoms. Because it is so uncommon, large-scale population studies often report it as absent or extremely infrequent, which is consistent with its classification as a pathogenic variant rather than a common benign genetic difference.
What This Information Means for You
If you have received information about this variant, it is essential to understand that genetic data is only one piece of a complex health puzzle. A pathogenic classification does not automatically guarantee a specific clinical outcome, as factors like age, environment, and other genetic modifiers can influence how a condition manifests. You cannot use this information to self-diagnose or predict the exact course of your health. If you are concerned about symptoms related to nerve function, such as muscle weakness or numbness, you should consult with a neurologist or a genetic counselor. These professionals can provide appropriate clinical testing, interpret results in the context of your personal and family medical history, and guide you through any necessary medical management or support.
How common is this variant?
The rs281865122 variant is extremely rare in the general population, appearing only in specific clinical cohorts rather than the general public.
Frequently asked questions
What is Charcot-Marie-Tooth disease type 1b?
CMT1B is a hereditary disorder that causes damage to the peripheral nerves. It typically results in muscle weakness and sensory loss in the limbs due to the breakdown of the myelin sheath.
Is rs281865122 a common genetic variant?
No, this variant is very rare. It is not a common genetic difference found in the general population.
Can I use this information to diagnose myself?
No. Genetic variants must be interpreted by a qualified healthcare professional in the context of your physical symptoms and medical history. Never attempt to self-diagnose based on genetic data.
What should I do if I have this variant?
If you have been identified as a carrier of this variant, you should discuss the results with a genetic counselor or a neurologist. They can help you understand the clinical implications and determine if any monitoring is necessary.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs281865122?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29